Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The company operates eight interdisciplinary clinics in Germany with a focus on acute care, medical rehabilitation, and specialized therapies for neurological, orthopedic, geriatric, cardiological, psychosomatic and pediatric patients. It treats approximately 45,000 inpatients annually across its network of facilities[4][5].
Some locations participate in multi-center Phase I/II clinical studies as study sites but the group itself does not develop drugs or biologics[6].
Patient satisfaction studies highlight high quality of care and positive outcomes in medical rehabilitation settings[9].
No proprietary drug pipeline.
Notable for integrating electronic health records and digital prescription systems at some sites[6].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on m&i-Klinikgruppe Enzensberg.